Associated Papers
Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis.
Mozafari S et al.
Bmc Genomics, 2024
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Perera SD et al.
Current Opinion in Lipidology, 2024
Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.
Jasim AA et al.
Frontiers in Genetics, 2018
APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.
Oliva I et al.
Clinical Science (london, England : 1979), 2016
Association of Apolipoprotein A5 Gene Polymorphisms with Metabolic Syndrome in the Korean Population.
Kim YR et al.
Genetic Testing and Molecular Biomarkers, 2016
Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients.
Lakbakbi El Yaagoubi F et al.
Pathologie-biologie, 2015
Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndrome.
Ajjemami M et al.
Journal of Diabetes and Metabolic Disorders, 2015
Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.
Ye H et al.
Plos One, 2015
Absence of Association between -1131T>C Polymorphism in the Apolipoprotein APOA5 Gene and Pediatric Metabolic Syndrome.
Fatemi SG et al.
Iranian Journal of Pediatrics, 2014
Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.
Halalkhor S et al.
Journal of Diabetes and Metabolic Disorders, 2014
Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.
Zhou J et al.
Molecular Medicine Reports, 2013
Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.
Can Demirdöğen B et al.
Molecular Biology Reports, 2012
Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: a meta-analysis.
Liu CF et al.
Genetic Testing and Molecular Biomarkers, 2012
Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry, 2012
Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.
Yin RX et al.
Plos One, 2011
APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
Sánchez-Moreno C et al.
The Journal of Nutrition, 2011
Association of apolipoprotein A5 gene promoter region -1131T>C with risk of stroke in Han Chinese.
Li X et al.
European Journal of Internal Medicine, 2011
Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians.
AshokKumar M et al.
Molecular Biology Reports, 2010
Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes.
Li X et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban, 2008
[Association of apolipoprotein A5 gene -1131T/C polymorphism with serum lipids and carotid intima-media thickness in patients with type 2 diabetes mellitus].
Qiao Y et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition, 2008
[Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease].
Yu Y et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences, 2007
APOA5 variants and metabolic syndrome in Caucasians.
Grallert H et al.
Journal of Lipid Research, 2007
Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Lai CQ et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
Talmud PJ et al.
Diabetologia, 2006
Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.
Vaessen SF et al.
Journal of Lipid Research, 2006
Association between apolipoprotein A5 - 1131T > C polymorphism and susceptibility of coronary artery disease in Chinese.
Tang YB et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2005
A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
Bi N et al.
Molecular Genetics and Metabolism, 2004
Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population.
Li GP et al.
Clinical Genetics, 2004
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.
Szalai C et al.
Atherosclerosis, 2004